SCHEMBL5310754

SCHEMBL5310754

O=C(Nc1nccs1)c1ccc(-c2ccc(C(=O)c3ccccc3C(F)(F)F)cc2)nn1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SCD O00767 3/20 0.48
NPC1 O15118 6/20 0.46
RAB9A P51151 5/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
METAP2 P50579 1/20 0.46
METAP1 P53582 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CYP1A2 P05177 1/20 0.44
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
PKM P14618 1/20 0.43
HPGD P15428 1/20 0.43
GAA P10253 2/20 0.43
CYP3A4 P08684 1/20 0.42
ADORA2A P29274 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5313732 0.91 NPC1 (0.46) SCDNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL5315546 0.87 SCD (0.51) SCDNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL5312258 0.82 SCD (0.47) SCDNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL5311233 0.82 NPC1 (0.51) SCDNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL5310095 0.79 KCNMA1 (0.48) NPC1RAB9ASMN1; SMN2LMNAL3MBTL1
Bromide SCHEMBL27908387 0.78 CYP1A2 (0.66) NPC1RAB9ASMN1; SMN2LMNAMETAP2
SCHEMBL5309718 0.76 ADORA2A (0.45) SCDNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL5313105 0.75 SCD (0.44) SCDNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL937227 0.73 SCD (0.77) SCD
SCHEMBL5314293 0.71 ADORA2A (0.47) NPC1RAB9ASMN1; SMN2LMNAMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044085-A2 HETEROARYL COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2007-04-19 WO disclosed